COMPASS Pathways plc - 8-K Filing
Compass Pathways reports Q3 2026 results with $444M cash position and imminent NDA submission for COMP360. (Items: 2.02 of this Form 8-K (including Exhibit 99)
Tickers: $CMPS
Read the full article at SEC EDGAR
Part of the story Compass Pathways to Submit FDA New Drug Application for COMP360 Within Two Weeks (3 articles)